Lloyd Price

SEPTEMBER 2, 2023

Exec Summary: The European HealthTech M&A market is expected to remain active in 2023, albeit with some slowdown from the record-breaking levels seen in 2022. This growth is expected to create opportunities for M&A activity, as pharmaceutical companies look to acquire smaller, innovative biotech companies.

Life Science 64

Life Science Digital Health EHR BioTech 64

Healthcare IT Today

OCTOBER 11, 2023

Welcome to the special HLTH 2023 edition of Healthcare IT Today Bonus Features. Senior care company DOUS announced the DUOS+AI platform , a conversational AI tool for members enrolled in Medicare Advantage. Elation Health released an integrated EHR and billing suite for primary care.

Life Science 71

Life Science EHR BioTech RCM 71

Healthcare IT Today

SEPTEMBER 24, 2023

News and Studies The American Telemedicine Association released three tools aimed at addressing disparity and inequity in care : Digital Infrastructure Disparities Score and Map, Economic and Social Value-Added Calculator, and a toolkit including all previously released resources.

Medical Billing 112

Medical Billing EHR Medicare BioTech 112

Digital Health Global

MARCH 4, 2024

This is the second cohort for the One Mind Accelerator since the program’s launch in 2023. Ellipsis Health has developed the first-ever voice-based biomarker powered co-pilot for behavioral health by layering on case management, primary care, and urgent care calls.

Mental health 88

Mental health BioTech Digital Health Psychiatry 88

Digital Health Global

FEBRUARY 7, 2023

3CC prioritizes early-stage investments in “Third Culture entrepreneurs” whose unique perspectives have the potential to help transform healthcare and address health disparities by optimizing care delivery in healthtech and biotech. Ciba Health was recently named among NY Digital Health 100 winners for 2023.

Chronic pain management 88

Chronic pain management BioTech Pain management Healthcare Innovation 88

Healthcare IT Today

JANUARY 8, 2024

The excitement around new tools took hold of all industries in 2023, and the potential is expansive. In 2023, Pear Therapeutics filed for bankruptcy and Akili abandoned the prescription business model. The trend is driven by a growing focus on health equity and proactive, personalized care. Dave Latshaw, CEO at BioPhy 1.

Health IT 85

Health IT Drug Development Pharmaceuticals BioTech 85